February 6, 2020

Restored knee function transforms patient’s life, inspires giving

By MayoRegMed
James Reibel, M.D., and Barbara Reibel

Mayo Clinic benefactors James Reibel, M.D., and Barbara Reibel were always on the go — even in retirement. That is until Dr. Reibel’s chronic knee pain became debilitating and threatened the couple’s active lifestyle. Their 25-year patient history with Mayo Clinic led the couple back to Mayo where they learned about regenerative medicine techniques available through the Regenerative Medicine Therapeutics Suites at Mayo Clinic’s campus in Florida. 

Read more about Dr. Reibel’s restored knee function and how Dr. and Mrs. Reibel’s experiences at Mayo Clinic inspired them to give back in Mayo Clinic Magazine.

Tags: knee pain, Mayo Clinic Center for Regenerative Medicine, Mayo Clinic in Florida, Practice, stem cells

A great story. One procedure, and one week later significant pain relief. BRAVO ZULU to the Mayo Clinic.

Two questions for the MC…

1. How closely is the MC working with the FDA, to gain FDA approval for the stem cell knee procedure that the doctor underwent?

2. When does the MC anticipate FDA approval for stem cell knee procedures?

COMMENT
@patriotmarine

A great story. One procedure, and one week later significant pain relief. BRAVO ZULU to the Mayo Clinic.

Two questions for the MC…

1. How closely is the MC working with the FDA, to gain FDA approval for the stem cell knee procedure that the doctor underwent?

2. When does the MC anticipate FDA approval for stem cell knee procedures?

Jump to this post

Hello – thank you for reading! At Mayo Clinic we work closely with our Office of Research and Regulatory Support to ensure our providers are in full compliance with current federal regulations when using regenerative products, including cellular, non-cellular and tissue products, for medical conditions. Additionally, experts in the Center for Regenerative Medicine regularly engage the FDA when conducting scientific clinical trials, putting in action the recognized principles of safe and responsible translation of regenerative therapies in line with FDA recommended best practices for scientists and providers in the regenerative medicine space. Additionally, the FDA granted permission for the procedure in this article through IND (Investigational New Drug) use.

COMMENT
Please login or register to post a reply.
Contact Us · Privacy Policy